Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study

BACKGROUND: Dipeptidyl peptidase 4 (DPP4) is a cell surface protein that can act as a tumor suppressor or activator, depending upon the level of expression and interaction with the microenvironment and chemokines. DPP4 inhibitors are used to treat diabetes. METHODS: We conducted this Surveillance Ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishnoi, Rohit, Hong, Young‐Rock, Shah, Chintan, Ali, Azka, Skelton, William P., Huo, Jinhai, Dang, Nam H., Dang, Long H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639187/
https://www.ncbi.nlm.nih.gov/pubmed/31124302
http://dx.doi.org/10.1002/cam4.2278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639187/
https://www.ncbi.nlm.nih.gov/pubmed/31124302
http://dx.doi.org/10.1002/cam4.2278

Ejemplares similares